MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on October 31, 2008; DOI: 10.1124/mol.108.047845


0026-895X/09/7502-363-373$20.00
Mol Pharmacol 75:363-373, 2009

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.108.047845v1
75/2/363    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, C.-W.
Right arrow Articles by Chen, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, C.-W.
Right arrow Articles by Chen, J. D.

Preferential Physical and Functional Interaction of Pregnane X Receptor with the SMRT{alpha} Isoform

Chia-Wei Li1, Gia Khanh Dinh, and J. Don Chen

Department of Pharmacology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway, New Jersey

The silencing mediator for retinoid and thyroid hormone receptors (SMRT) serves as a platform for transcriptional repression elicited by several steroid/nuclear receptors and transcription factors. SMRT exists in two major splicing isoforms, {alpha} and {tau}, with SMRT{alpha} containing only an extra 46-amino acid sequence inserted immediately downstream from the C-terminal corepressor motif. Little is known about potential functional differences between these two isoforms. Here we show that the pregnane X receptor (PXR) interacts more strongly with SMRT{alpha} than with SMRT{tau} both in vitro and in vivo. It is interesting that the PXR-SMRT{alpha} interaction is also resistant to PXR ligand-induced dissociation, in contrast to the PXR-SMRT{tau} interaction. SMRT{alpha} consistently inhibits PXR activity more efficiently than does SMRT{tau} in transfection assays, although they possess comparable intrinsic repression activity and association with histone deacetylase. We further show that the mechanism for the enhanced PXR-SMRT{alpha} interaction involves both the 46-amino acid insert and the C-terminal corepressor motif. In particular, the first five amino acids of the SMRT{alpha} insert are essential and sufficient for the enhanced binding of SMRT{alpha} to PXR. Furthermore, we demonstrate that Tyr2354 and Asp2355 residues of the SMRT{alpha} insert are most critical for the enhanced interaction. In addition, expression data show that SMRT{alpha} is more abundantly expressed in most human tissues and cancer cell lines, and together these data suggest that SMRT{alpha} may play a more important role than SMRT{tau} in the negative regulation of PXR.


Received for publication April 10, 2008.

Accepted for publication October 30, 2008.

Address correspondence to: Dr. J. Don Chen, Department of Pharmacology, UMDNJ-Robert Wood Johnson Medical School, 661 Hoes Lane, Piscataway, NJ 08854-5635. E-mail: chenjd{at}umdnj.edu







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2009 by the American Society for Pharmacology and Experimental Therapeutics